<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-pharmaceuticals-12-00157">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bhattacharjee</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Geyer</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Woodard</surname>
    <given-names>C.L.</given-names>
   </name>
   <name>
    <surname>Kathcart</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Nichols</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Prigge</surname>
    <given-names>S.T.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Mott</surname>
    <given-names>B.T.</given-names>
   </name>
   <name>
    <surname>Waters</surname>
    <given-names>N.C.</given-names>
   </name>
  </person-group>
  <article-title>A three dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors</article-title>
  <source>J. Med. Chem.</source>
  <year>2004</year>
  <volume>47</volume>
  <fpage>5418</fpage>
  <lpage>5426</lpage>
  <pub-id pub-id-type="doi">10.1021/jm040108f</pub-id>
  <pub-id pub-id-type="pmid">15481979</pub-id>
 </element-citation>
</ref>
